Table 2.
Risk factors | Before multiply-imputed | After multiply-imputed | ||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Sex | ||||
Male | 1 | 1 | ||
Female | 1.14 (0.82–1.58) | 0.44 | 1.14 (0.82–1.58) | 0.44 |
Age at onset, years | ||||
< 18 | 1 | 1 | ||
18–49 | 7.23 (2.25–23.18) | < 0.001 | 7.23 (2.25–23.18) | < 0.001 |
≥ 50 | 10.89 (3.44–34.51) | < 0.001 | 10.89 (3.44–34.51) | < 0.001 |
Symptoms at onset | ||||
Ptosis | 1 | 1 | ||
Diplopia/diplopia and ptosis | 1.48 (1.07–2.06) | 0.02 | 1.48 (1.07–2.06) | 0.02 |
Comorbid autoimmune diseasesa | ||||
No | 1 | 1 | ||
Yes | 0.89 (0.37–2.18) | 0.81 | 0.89 (0.37–2.18) | 0.81 |
RNS findings | ||||
Normal | 1 | 1 | ||
Abnormal | 3.32 (2.19–5.03) | < 0.001 | 3.51 (2.37–5.19) | < 0.001 |
AChR-Ab | ||||
Seronegative | 1 | 1 | ||
Seropositive | 5.09 (2.59–10.02) | < 0.001 | 4.61 (2.49–8.52) | < 0.001 |
Thymic status | ||||
Non-thymoma | 1 | 1 | ||
Thymoma | 2.13 (1.46–3.11) | < 0.001 | 2.14 (1.46–3.12) | < 0.001 |
CI Confidence interval, HR hazard ratio
aComorbid autoimmune diseases included systemic lupus erythematosus, multiple sclerosis, rheumatoid arthritis, Hashimoto's thyroiditis, and optic neuromyelitis spectrum disease